Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma Receives Sahpra Approval To Manufacture And Market Generic Semaglutide In South Africa

BRIEF-Sun Pharma Receives Sahpra Approval To Manufacture And Market Generic Semaglutide In South Africa

- Sun Pharmaceutical Industries Ltd SUN.NS:

  • SUN PHARMA - PHARMA RECEIVES SAHPRA APPROVAL TO MANUFACTURE AND MARKET GENERIC SEMAGLUTIDE IN SOUTH AFRICA

Source text: ID:nBSE9KDTCd

Further company coverage: SUN.NS


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news